Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLISTA COLLTECH LIMITED Director's Dealing 2016

Apr 7, 2016

65044_rns_2016-04-07_b496fef5-e7f0-4086-8936-d07e7f168a49.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Holista Colltech Limited
ACN 094 515 992

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Rajendran Marnickavasagar
Date of last notice 12 November 2013

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct & Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Galen Biomedical Inc
Date of change 1 April 2016
No. of securities held prior to change 73,914,400 Ordinary Shares
Class Ordinary Shares
Number acquired 58,514,245 Ordinary Shares
Number disposed 58,514,245 Ordinary Shares
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Non cash consideration under Share Sale
Agreement
No. of securities held after change Direct
15,400,155 Ordinary Shares
Indirect
58,514,245
  • See chapter 19 for defined terms. 01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Off-market transfer from Direct interest to
Indirect interest as agreed by Shareholders at the
AGM held on 24 November 2015.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract -
Nature of interest -
Name of registered holder
(if issued securities)
-
Date of change -
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
-
Interest acquired -
Interest disposed -
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
-
Interest after change -

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above
traded during a+closed period where prior written clearance
was required?
No
If so, was prior written clearance provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 2